Novartis Vaccines and Diagnostics

Italy

1 December 2019 - 30 November 2020

No articles found. Novartis Vaccines and Diagnostics did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

GlaxoSmithKline plc. (GSK)

↳ Novartis Vaccines and Diagnostics

Cellzome GmbH

Cellzome Ltd.

GSK Neural Pathways Discovery Performance Unit, Singapore

GSK Vaccines Institute for Global Health Srl

Novartis Vaccines Institute for Global Health (NVGH)

GlaxoSmithKline (GSK) Jurong

GlaxoSmithKline AG, Switzerland

GlaxoSmithKline Australia Pty. Ltd.

GlaxoSmithKline Belgium

GlaxoSmithKline Clinical Unit Cambridge

GlaxoSmithKline France

GlaxoSmithKline Medicines Research Centre

GlaxoSmithKline Montrose

GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline R&D Bangalore

GlaxoSmithKline R&D China

GlaxoSmithKline R&D Verona

GlaxoSmithKline Spain

GlaxoSmithKline Stevenage

GlaxoSmithKline USA

GlaxoSmithKline R&D Cambridge

GlaxoSmithKline R&D Collegeville

GlaxoSmithKline R&D King of Prussia

GlaxoSmithKline R&D Research Triangle Park

Global Vaccines R&D Centre Rockville

GlaxoSmithKline Vaccines (GSK Vaccines)

GlaxoSmithKline Vaccines Singapore

GlaxoSmithkline Beecham Plc.

Glycovaxyn AG

Human Genome Sciences, Inc.

Novartis Vaccines and Diagnostics GmbH

Novartis Vaccines and Diagnostics, Inc.

Chiron Corporation

PathoGenesis Corporation

Novartis Vaccines and Diagnostics, Inc. - Cambridge

Okairos AG

Okairos AG, Rome

Sirtris Pharmaceuticals, Inc.

TESARO, Inc.

Return to institution outputs

Latest supplement

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free